Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2025-03-20

Clinical Trial Update: PROcalcitonin Impact on Antibiotic Reduction, adverSe Events and AVoidable healthcarE Costs (ProSAVE): A RCT [NA]

View source ↗

Summary

This randomized controlled trial (ProSAVE) evaluates whether procalcitonin-guided antibiotic therapy reduces antibiotic use, adverse events, and avoidable healt…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Procalcitonin-guided antibiotic therapy (procalcitonin-guided antibiotic therapy)

Snippet

Sponsor: Massachusetts General Hospital | Conditions: Pneumonia, Bacterial | NA | Status: COMPLETED | Results posted: 2025-03-20